Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
CD1A encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. Additionally we are shipping CD1a Molecule Proteins (5) and CD1a Molecule Kits (1) and many more products for this protein.
Showing 10 out of 482 products:
Human Monoclonal CD1A Primary Antibody for WB - ABIN396835
Zeissig, Dougan, Barral, Junker, Chen, Kaser, Ho, Mandel, McIntyre, Kennedy, Painter, Veerapen, Besra, Cerundolo, Yue, Beladi, Behar, Chen, Gumperz, Breckpot, Raper, Baer, Exley, Hegele, Cuchel et al.: Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function. ... in The Journal of clinical investigation 2010
Show all 5 references for ABIN396835
Dog (Canine) Monoclonal CD1A Primary Antibody for FACS - ABIN119666
Burrone, Milstein: Control of HLA-A,B,C synthesis and expression in interferon-treated cells. in The EMBO journal 1984
Show all 4 references for ABIN119666
Pig (Porcine) Monoclonal CD1A Primary Antibody for FACS - ABIN371280
Denham, Shimizu, Bianchi, Zwart, Carr, Parkhouse: Monoclonal antibodies recognising differentiation antigens on porcine B cells. in Veterinary immunology and immunopathology 1995
Show all 3 references for ABIN371280
Human Monoclonal CD1A Primary Antibody for IHC (p) - ABIN180684
Aractingi, Gluckman, Dauge-Geffroy, Le Goué, Flahaut, Dubertret, Carosella: Langerhans' cells are depleted in chronic graft versus host disease. in Journal of clinical pathology 1997
Show all 3 references for ABIN180684
Dog (Canine) Monoclonal CD1A Primary Antibody for FACS - ABIN119669
McMichael, Pilch, Galfré, Mason, Fabre, Milstein: A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. in European journal of immunology 1979
Show all 3 references for ABIN119669
Dog (Canine) Monoclonal CD1A Primary Antibody for FACS, IHC (fro) - ABIN119667
Galkowska, Waldemar, Wojewodzka: Reactivity of antibodies directed against human antigens with surface markers on canine leukocytes. in Veterinary immunology and immunopathology 1997
Show all 3 references for ABIN119667
Human Monoclonal CD1A Primary Antibody for ICC, IHC - ABIN969017
Adachi, Horie, Kitamura, Nakamura, Taniguchi, Miwa, Fujioka, Nishimura, Hayashi: CD1a expression in PEComas. in Pathology international 2008
Show all 2 references for ABIN969017
Human Monoclonal CD1A Primary Antibody for FACS, IF - ABIN1106008
Stein, Gerdes, Schwab, Lemke, Mason, Ziegler, Schienle, Diehl: Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. in International journal of cancer. Journal international du cancer 1983
Show all 2 references for ABIN1106008
Human Monoclonal CD1A Primary Antibody for FACS, ELISA - ABIN969016
Kuijf, Geleijns, Ennaji, van Rijs, van Doorn, Jacobs: Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms. in Journal of neuroimmunology 2008
Show all 2 references for ABIN969016
The data show that immunohistochemistry for CD1a and Hsp60 (show HSPD1 Antibodies) can be of help in differential diagnosis between Keratoacantomas and well-differentiated forms of squamous cell carcinomas.
NDN (show NDN Antibodies) and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas
Findings suggest that dermal survivin (show BIRC5 Antibodies)+CD1a+ (CD1a antigen) cell infiltration may be a potential biomarker of systemic sclerosis skin lesions.
plasma-derived lipids drive functional levels of CD1d (show CD1D Antibodies) expression.
Studies indicate that many CD1 antigen-restricted T cells do not require foreign antigens for activation but instead can be activated by self-lipids presented by CD1.
High CD1a-positive dendritic cell density is associated with improved disease-free survival in papillary thyroid carcinoma.
the expression of WNT4 (show WNT4 Antibodies), a Wnt (show WNT2 Antibodies) ligand, and three targets of Wnt (show WNT2 Antibodies)-ss-catenin transcription activation, namely, MMP7 (show MMP7 Antibodies), cyclinD1 (CD1) and c-MYC (show MYC Antibodies) in 141 penile tissue cores from 101 unique samples, were investigated.
Studies indicate that the antigen-presenting molecules CD1 and MHC class I-related protein (MR1 (show MR1 Antibodies)) display lipids and small molecules to T cells.
The presence of CD1a(+) T-cells in all of the LCH lesions that we have studied to date warrants further investigation into their biological function to determine whether these cells are important in the pathogenesis of LCH
A polymorphism in human CD1A is associated with susceptibility to tuberculosis.
reduced development of atherosclerosis in hyperlipidaemic mice by the NKT (show CTSL1 Antibodies) antagonist, without affecting NKT (show CTSL1 Antibodies) cell or other lymphocyte numbers, suggests that targeting lesion inflammation via CD1d (show CD1D Antibodies)-dependent activation of NKT (show CTSL1 Antibodies) cells
the crystal structure of the first peptide identified to bind CD1d (show CD1D Antibodies), p99 (show PPP1R10 Antibodies), and show that it binds in the antigen-binding groove of CD1d (show CD1D Antibodies) in a manner compatible with its presentation to T cell receptors.
regulatory and protective role of CD1d (show CD1D Antibodies)-dependent natural killer T cells in contact hypersensitivity, at least in part via regulation of IL-10 (show IL10 Antibodies) producing B(regs)
The findings support a model in which low endosomal pH controls stability and lipid raft localization of CD1d (show CD1D Antibodies)-glycolipid complexes to regulate the outcome of iNKT cell mediated responses.
affects iNKT cell activation by mast cells and release of both IFN-gamma (show IFNG Antibodies) and IL-13 (show IL13 Antibodies)
CD1d (show CD1D Antibodies) acts as a cell surface receptor that recognizes and binds oxysterols and initializes a pathway connecting oxysterol binding to PPARgamma (show PPARG Antibodies) activation
Our results indicate that genetically controlled physiological variation of CD1d (show CD1D Antibodies) expression levels modulates iNKT-cell development.
our results demonstrate that both Ets1 (show ETS1 Antibodies) and miR (show MLXIP Antibodies)-155 can directly regulate the expression of CD1d (show CD1D Antibodies) on B-cells
We report a novel dichotomous role of beta2m and CD1d, whereby these molecules differently regulate autoimmunity against phospholipid versus non-phospholipid autoantigens.
CD1d (show CD1D Antibodies) is up-regulated in early adipogenesis, and is transcriptionally controlled by CCAAT/enhancer-binding protein (C/EBP)-beta (show CEBPB Antibodies) and -delta.
This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to the plasma membrane and to recycling vesicles of the early endocytic system. Alternatively spliced transcript variants have been observed, but their biological validity has not been determined.
, CD1.2 antigen
, CD1A antigen, a polypeptide
, CD1a molecule
, T-cell surface glycoprotein CD1A2 antigen
, T-cell surface glycoprotein CD1b
, a polypeptide
, T-cell surface glycoprotein CD1a
, T-cell surface antigen T6/Leu-6
, cluster of differentiation 1 A
, cortical thymocyte antigen CD1A
, differentiation antigen CD1-alpha-3
, epidermal dendritic cell marker CD1a
, hTa1 thymocyte antigen
, CD1b molecule
, T-cell surface glycoprotein CD1d1
, antigen-presenting glycoprotein CD1d1